Press

Corporate - 2026
The Vicenza-based company is investing in under-30 talent to drive forward new, high-innovation projects. Over the past year, ASA has welcomed eight recent school leavers and graduates into the...
Research - 2026
New scientific evidence supports the use of ASAveterinary's MLS® technology in the management of complex musculoskeletal disorders in veterinary medicine. Two studies, conducted in collaboration with...
Corporate - 2026
The Vicenza-based company, specialised in the production of laser therapies and devices for human and veterinary care, is closing out 2025 with a focus on training and innovation through ongoing...
Corporate - 2025
The Vicenza-based company closed out 2025 with a celebration of diversity. For the holiday season, ASA invited its staff to take part in a ‘journey into the value of intergenerational dialogue’,...
Corporate - 2025
To mark the month dedicated to combating violence against women, the two Vicenza-based entities have joined forces to promote a culture of acceptance and gender equality
Research - 2025
Recent research and pilot studies highlight the benefits of laser therapy in treating radiodermatitis and peripheral neuropathy induced by radiation and chemotherapy for breast cancer.